idecabtagene vicleucel
2seventy bio,bms
#ims2022 | great to see the initial experiences with novel #cartcell therapies in real-world. doris hansen shares the data of ide-cel, including patients who were previously exposed to bcma-directed therapies #mmsm watch our interview from #asco22: 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma